Wed, July 20, 2022
Tue, July 19, 2022
Mon, July 18, 2022

Ken Cacciatore Upgraded (TAK) to Buy and Increased Target to $24 on, Jul 19th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-24-on-jul-19th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ken Cacciatore of Cowen & Co., Upgraded "Takeda Pharmaceutical Company Limited" (TAK) to Buy and Increased Target from $21 to $24 on, Jul 19th, 2022.

Ken, nor any peers, have made any analyst calls on TAK in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources